Open AccessTrial of Roflumilast Cream for Chronic Plaque Psoriasis
Author(s) -
Mark Lebwohl,
Kim Papp,
Linda Stein Gold,
Melinda Gooderham,
Leon Kircik,
Zoe Draelos,
Steven Kempers,
Mathew Zirwas,
Kathleen Smith,
David W. Osborne,
MarieLouise Trotman,
Lynn Navale,
Charlotte Merritt,
David R. Berk,
Howard G. Welgus
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2000073
Subject(s) - roflumilast , psoriasis , plaque psoriasis , medicine , dermatology , apremilast , pulmonary disease , psoriatic arthritis
Systemic oral phosphodiesterase type 4 (PDE-4) inhibitors have been effective in the treatment of psoriasis. Roflumilast cream contains a PDE-4 inhibitor that is being investigated for the topical treatment of psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom